A group of influential scientists have urged that clinical use of CRISPR be put on hold in the wake of the Chinese gene-edited baby debacle. The call to suspend research on heritable germline DNA is reminiscent of the self-imposed moratorium when gene therapy first emerged in the 1970s. It is also a reminder that maintaining ethical standards is critical during the frothy times surrounding exciting novel medical technologies.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,